166 related articles for article (PubMed ID: 20577872)
61. The role of hip and chest radiographs in osteoporotic evaluation among south Indian women population: a comparative scenario with DXA.
Kumar DA; Anburajan M
J Endocrinol Invest; 2014 May; 37(5):429-40. PubMed ID: 24737214
[TBL] [Abstract][Full Text] [Related]
62. Osteoporosis case finding in the general practice: phalangeal radiographic absorptiometry with and without risk factors for osteoporosis to select postmenopausal women eligible for lumbar spine and hip densitometry.
Gasser KM; Mueller C; Zwahlen M; Kaufmann M; Fuchs G; Perrelet R; Abetel G; Bürgi U; Lippuner K
Osteoporos Int; 2005 Nov; 16(11):1353-62. PubMed ID: 15711776
[TBL] [Abstract][Full Text] [Related]
63. Osteoporosis: diagnosis with lateral and posteroanterior dual x-ray absorptiometry compared with quantitative CT.
Guglielmi G; Grimston SK; Fischer KC; Pacifici R
Radiology; 1994 Sep; 192(3):845-50. PubMed ID: 8058958
[TBL] [Abstract][Full Text] [Related]
64. The usefulness of dual energy X-ray and laser absorptiometry of the calcaneus versus dual energy X-ray absorptiometry of hip and spine in diagnosing manifest osteoporosis.
de Klerk G; van der Velde D; van der Palen J; van Bergeijk L; Hegeman JH
Arch Orthop Trauma Surg; 2009 Feb; 129(2):251-7. PubMed ID: 18825395
[TBL] [Abstract][Full Text] [Related]
65. Device-specific weighted T-score for two quantitative ultrasounds: operational propositions for the management of osteoporosis for 65 years and older women in Switzerland.
Hans D; Hartl F; Krieg MA
Osteoporos Int; 2003 May; 14(3):251-8. PubMed ID: 12730788
[TBL] [Abstract][Full Text] [Related]
66. Vertebral bone attenuation on low-dose chest CT: quantitative volumetric analysis for bone fragility assessment.
Kim YW; Kim JH; Yoon SH; Lee JH; Lee CH; Shin CS; Park YS
Osteoporos Int; 2017 Jan; 28(1):329-338. PubMed ID: 27480628
[TBL] [Abstract][Full Text] [Related]
67. Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
Sanfélix-Genovés J; Sanfélix-Gimeno G; Peiró S; Hurtado I; Fluixà C; Fuertes A; Campos JC; Giner V; Baixauli C
Osteoporos Int; 2013 Mar; 24(3):1045-55. PubMed ID: 22618269
[TBL] [Abstract][Full Text] [Related]
68. Barriers to secondary fracture prevention in primary care.
Mendis AS; Ganda K; Seibel MJ
Osteoporos Int; 2017 Oct; 28(10):2913-2919. PubMed ID: 28664275
[TBL] [Abstract][Full Text] [Related]
69. Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
Bilezikian JP; Hattersley G; Fitzpatrick LA; Harris AG; Shevroja E; Banks K; Leder BZ; Zanchetta JR; Hans D
Osteoporos Int; 2018 Feb; 29(2):323-328. PubMed ID: 29167971
[TBL] [Abstract][Full Text] [Related]
70. Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.
Watts NB; Hattersley G; Fitzpatrick LA; Wang Y; Williams GC; Miller PD; Cosman F
Osteoporos Int; 2019 Jun; 30(6):1187-1194. PubMed ID: 30899994
[TBL] [Abstract][Full Text] [Related]
71. Secondary prevention of osteoporotic fractures--an "OPTIMAL" model of care from Singapore.
Chandran M; Tan MZ; Cheen M; Tan SB; Leong M; Lau TC
Osteoporos Int; 2013 Nov; 24(11):2809-17. PubMed ID: 23615816
[TBL] [Abstract][Full Text] [Related]
72. Influence of bone densitometry results on the treatment of osteoporosis.
Fitt NS; Mitchell SL; Cranney A; Gulenchyn K; Huang M; Tugwell P
CMAJ; 2001 Mar; 164(6):777-81. PubMed ID: 11276543
[TBL] [Abstract][Full Text] [Related]
73. Evaluation of the need for a fracture liaison service in a patient-centered medical home.
Crissman JK; Woodall T; LaVallee L; Masterson J; Clouse L; Galvin SL; Scott MA
J Am Pharm Assoc (2003); 2019; 59(4):565-569. PubMed ID: 30948237
[TBL] [Abstract][Full Text] [Related]
74. Can the WHO criteria for diagnosing osteoporosis be applied to calcaneal quantitative ultrasound?
Frost ML; Blake GM; Fogelman I
Osteoporos Int; 2000; 11(4):321-30. PubMed ID: 10928222
[TBL] [Abstract][Full Text] [Related]
75. Should women be screened for osteoporosis at midlife?
de Villiers TJ
Climacteric; 2018 Jun; 21(3):239-242. PubMed ID: 29447485
[TBL] [Abstract][Full Text] [Related]
76. Effect of single dose intravenous zoledronic acid on bone mineral density in post-menopausal osteoporosis of Bangladeshi women.
Hossain M; Chowdhury IH; Emran MA; Habib AH; Asaduzzamnan AK; Alam M; Ferdous C
Bangladesh Med Res Counc Bull; 2010 Dec; 36(3):74-7. PubMed ID: 21548542
[TBL] [Abstract][Full Text] [Related]
77. Phalangeal densitometry compared with dual energy X-ray absorptiometry for assessment of bone mineral density in elderly women.
Dhainaut A; Rohde G; Hoff M; Syversen U; Haugeberg G
J Womens Health (Larchmt); 2011 Dec; 20(12):1789-95. PubMed ID: 21970521
[TBL] [Abstract][Full Text] [Related]
78. ADDING VFA TO DXA IDENTIFIES FRACTURE RISK IN A WAY NOT DUPLICATED BY OTHER MEASURES.
Ginther JP; Ginther AW; Brodersen LD
Endocr Pract; 2017 Dec; 23(12):1375-1378. PubMed ID: 29019717
[TBL] [Abstract][Full Text] [Related]
79. Factors related with osteoporosis treatment in postmenopausal women.
Rossi LMM; Copes RM; Dal Osto LC; Flores C; Comim FV; Premaor MO
Medicine (Baltimore); 2018 Jul; 97(28):e11524. PubMed ID: 29995822
[TBL] [Abstract][Full Text] [Related]
80. An update of the prevalence of osteoporosis, fracture risk factors, and medication use among community-dwelling older adults: results from the Canadian Longitudinal Study on Aging (CLSA).
McArthur C; Lee A; Alrob HA; Adachi JD; Giangregorio L; Griffith LE; Morin S; Thabane L; Ioannidis G; Lee J; Leslie WD; Papaioannou A
Arch Osteoporos; 2022 Feb; 17(1):31. PubMed ID: 35122160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
